Cold atmospheric pressure plasma treatment shows promising results for the use in cancer therapy for in vitro and in vivo experiments. Even a selective effect on cancer cells is possible, but the underlying mechanisms need to be determined [1]. As plasmas are gaseous systems, important parts of the interaction between plasma and biological systems are mediated and modulated, by the liquid surrounding the treated cell or tissue. Small reactive oxygen or nitrogen species (RONS) serve as signaling molecules to modulate physiological processes within cells, for example via thiol-switches of cysteine residues within proteins [2]. These modifications lead to an altered enzymatic activity, or changes in protein expression levels as part of various redox signaling pathways. Many cancer cell types have a changed redox metabolism, offering the possibility to selectively target these cells with reactive molecules. It is hypothesized, that short-lived species generated by plasma may transfer their chemical energy to organic compounds within the biological liquids and such derivatives have a prolonged activity towards the cell. To challenge this hypothesis, we used cysteine as a model substance because of its important role in protein function. Its thiol group is able to undergo various covalent modifications and the molecule was successfully used to determine the chemical footprint of different plasma sources. Depending on plasma treatment parameters, the formation of various, potentially bioactive cysteine derivatives is possible [3]. Among them are disulfide-S-oxides, which can modify redox sensitive proteins [4]. Using various argon plasma jets with oxygen and nitrogen admixtures (kINPen MED, kINPen09, neoplas/neoplas tools) we treated cysteine in physiological buffer and applied the resulting product mix in various in vitro cell models. The effect on human keratinocytes, especially on their short and long term proliferative and migratory capability, the interleukin secretion, and the intracellular oxidative potential, was explored. To minimize the impact of plasma generated long lived ROS, catalase and a rest time between treatment and cell challenge was employed. In contrast to the hypothesis, no major impact on the tested cell functions was observed. Yet, interleukin secretion and intracellular ROS levels showed changes and will be discussed.
Read full abstract